Search - tctmd.com

Displaying 1 - 20 of 89

Sort: Relevancy | Date

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

Presentation TCT 2024

Lesion Preparation Innovations in IVL– Will Next Generation Devices Move the Needle?

Presenter: William Gray

October 30, 2024

Presentation TCT 2024

Final Results of the PATCH Study of the Vivasure PerQseal® System for Large Hole Closure

Presenter: William Gray

October 28, 2024

Presentation TCT 2024

Transforming Carotid Artery Stenting: Integrated Embolic Protection with Paladin and the Neuroguard 3-in-1 Carotid Stent System

Presenter: William Gray

October 28, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

News Conference News VIVA 2023

New Carotid Stent Systems Associated With Low Stroke Risk

L.A. McKeown

November 09, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

Patient-Level Meta-analysis on PTX Safety

Presenter: William Gray

October 24, 2023

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

L.A. McKeown

May 23, 2022

News Conference News VIVA 2020

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

L.A. McKeown

November 09, 2020

News Industry News

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

October 15, 2020

News Daily News

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

L.A. McKeown

July 02, 2020

News Conference News LINC 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

L.A. McKeown

January 28, 2020

News Conference News ISET 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

Caitlin E. Cox

January 24, 2020

News Conference News ISET 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Caitlin E. Cox

January 23, 2020

Presentation TCT 2019

Perspective: The Case for Ongoing Use of Drug-Eluting Technologies for PAD

Presenter: William Gray

September 27, 2019

Presentation TCT 2019

Emerging Drug-Free Platforms for the SFA: Can We Do Better Off Drugs?

Presenter: William Gray

September 26, 2019

News Daily News

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

Caitlin E. Cox

August 09, 2019

Advertisement

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

Lesion Preparation Innovations in IVL– Will Next Generation Devices Move the Needle?

Final Results of the PATCH Study of the Vivasure PerQseal® System for Large Hole Closure

Transforming Carotid Artery Stenting: Integrated Embolic Protection with Paladin and the Neuroguard 3-in-1 Carotid Stent System

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

New Carotid Stent Systems Associated With Low Stroke Risk

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Patient-Level Meta-analysis on PTX Safety

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

FDA’s First Take on New Paclitaxel Concerns in CLI

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Perspective: The Case for Ongoing Use of Drug-Eluting Technologies for PAD

Emerging Drug-Free Platforms for the SFA: Can We Do Better Off Drugs?

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content